Ontario study aims to match pancreatic cancer patients with tailored treatments
NCT ID NCT05927298
First seen Feb 23, 2026 · Last updated Apr 29, 2026 · Updated 9 times
Summary
This study is gathering information from 200 people with pancreatic cancer to see if analyzing their tumor's genes and creating mini-tumors in a lab can help doctors choose more personalized treatments. Participants provide tissue and blood samples, and researchers track their health outcomes. The goal is to learn whether this approach increases the number of patients receiving treatments matched to their specific cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.